Jerome Razanamahery

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levels.

Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levels.

Journal: British journal of haematology

Published: December 03, 2025

Erdheim-Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes.

Erdheim-Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes.

Journal: HemaSphere

Published: November 26, 2025

Orbital MRI for diagnosing giant cell arteritis in cases of anterior ischaemic optic neuropathy.

Orbital MRI for diagnosing giant cell arteritis in cases of anterior ischaemic optic neuropathy.

Journal: RMD open

Published: September 22, 2025

Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease.

Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease.

Journal: American journal of hematology

Published: September 20, 2025

Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk.

Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk.

Journal: Hematological oncology

Published: August 02, 2025

MEK inhibitors are effective in Erdheim-Chester disease regardless of MAPK pathway mutations.

MEK inhibitors are effective in Erdheim-Chester disease regardless of MAPK pathway mutations.

Journal: Leukemia

Published: March 12, 2025

Risk of Second Cancer in Erdheim-Chester Disease.

Risk of Second Cancer in Erdheim-Chester Disease.

Journal: JAMA oncology

Published: February 27, 2025

In Synergy With Interferon-γ, Interleukin-17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis.

In Synergy With Interferon-γ, Interleukin-17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 24, 2025

Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.

Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.

Journal: Leukemia

Published: February 11, 2025

Clinical Images: Penetrating aortic ulceration as an initial presentation of Erdheim-Chester disease.

Clinical Images: Penetrating aortic ulceration as an initial presentation of Erdheim-Chester disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 06, 2025

Identification of Key Predictors of Cryoglobulinemia Severity at Diagnosis: Threshold, Type, and Severity Score at Diagnosis.

Identification of Key Predictors of Cryoglobulinemia Severity at Diagnosis: Threshold, Type, and Severity Score at Diagnosis.

Journal: Journal of clinical medicine

Published: December 09, 2024

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Journal: Blood advances

Published: October 30, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026